PLASMA CITRATE IS ELEVATED IN SUBJECTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND IS ASSOCIATED WITH LIVER FIBROSIS

被引：0
|
作者：
Garcia, Erwin [1 ]
Shalaurova, Irina [1 ]
Jiang, Z. Gordon [2 ,3 ]
Lai, Michelle [4 ]
Connelly, Margery [1 ]
机构：
[1] Labcorp, Burlington, NC USA
[2] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA
[3] Beth Israel Deaconess Med Ctr, Div Gastroenterol & Hepatol, Boston, MA 02215 USA
[4] Harvard Med Sch, Div Gastroenterol & Hepatol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA
来源：
HEPATOLOGY | 2021年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1633
引用
收藏
页码：977A / 978A
页数：2
相关论文
共 50 条
  • [41] Vitamin E and nonalcoholic fatty liver disease (NAFLD)
    Thakur, Varsha
    Ulatowski, Lynn
    Parker, Robert
    Zhang, Renliang
    Liu, Xiuli
    Manor, Danny
    FASEB JOURNAL, 2013, 27
  • [42] Nutritional Management of Nonalcoholic fatty liver disease (NAFLD)
    Boudaoud, Amel Ait
    Rives-Lange, Claire
    Perregaux, Jean Francois
    Radu, Alina
    Messager-Josipowicz, Diane
    Barsamian, Charles
    Carette, Claire
    Czernichow, Sebastien
    PRESSE MEDICALE, 2019, 48 (12): : 1496 - 1501
  • [43] Intestinal permeability in nonalcoholic fatty liver disease (NAFLD).
    Miele, L
    Valenza, V
    Mascianà, R
    Gabrieli, ML
    Perotti, G
    Cammarota, G
    Montalto, M
    Forgione, A
    Vero, V
    Gasbarrini, G
    Grieco, A
    HEPATOLOGY, 2004, 40 (04) : 585A - 585A
  • [44] Fetuin-A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjects
    Sato, Motoya
    Kamada, Yoshihiro
    Takeda, Yuri
    Kida, Sachiho
    Ohara, Yuka
    Fujii, Hironobu
    Akita, Maaya
    Mizutani, Kayo
    Yoshida, Yuichi
    Yamada, Makoto
    Hougaku, Hidetaka
    Takehara, Tetsuo
    Miyoshi, Eiji
    LIVER INTERNATIONAL, 2015, 35 (03) : 925 - 935
  • [45] A clinical model to predict fibrosis on liver biopsy in paediatric subjects with nonalcoholic fatty liver disease
    Kulkarni, Sakil
    Naz, Nadia
    Gu, Hongjie
    Stoll, Janis M.
    Thompson, Michael D.
    DeBosch, Brian J.
    CLINICAL OBESITY, 2021, 11 (05)
  • [46] Die nichtalkoholische Fettlebererkrankung (NAFLD)Nonalcoholic fatty liver disease (NAFLD)
    S. Zeuzem
    C. Trautwein
    Der Gastroenterologe, 2020, 15 (2): : 77 - 77
  • [47] Pathology of nonalcoholic fatty liver disease (NAFLD) associated with obesity: pathogenetic mechanisms
    Alberto Videla, Luis
    Maria Obregon, Ana
    Pettinelli, Paulina
    MEDWAVE, 2011, 11 (07):
  • [48] Fibrosis-4 Index vs Nonalcoholic Fatty Liver Disease Fibrosis Score in Identifying Advanced Fibrosis in Subjects With Nonalcoholic Fatty Liver Disease: A Meta-Analysis
    Castellana, Marco
    Donghia, Rossella
    Guerra, Vito
    Procino, Filippo
    Castellana, Fabio
    Zupo, Roberta
    Lampignano, Luisa
    Sardone, Rodolfo
    De Pergola, Giovanni
    Romanelli, Francesco
    Trimboli, Pierpaolo
    Giannelli, Gianluigi
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 (09): : 1833 - 1841
  • [49] A STUDY OF RISK FACTORS ASSOCIATED WITH NONALCOHOLIC FATTY LIVER DISEASE [NAFLD] IN INDIANS
    Singh, S. P.
    Misra, D.
    Singh, A.
    Misra, B.
    Pati, G. K.
    Panigrahi, M. K.
    Kar, S. K.
    Meher, C.
    Agrawal, O.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S352 - S352
  • [50] Thymoquinone reverses nonalcoholic fatty liver disease (NAFLD) associated with experimental hypothyroidism
    Ayuob, Nasra Naeim
    Abdel-Hamid, Ahmed Abdel-Hamid Mohamed
    Helal, Ghada Mohamed Moneir
    Mubarak, Wafaa Alaa
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2019, 60 (02): : 479 - 486
12345